CAS Medical Systems is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The company’s FORE-SIGHT Absolute Cerebral Oximeter is the only cerebral oximeter available with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for patients of all types.
The company announced today the publication of a study illustrating the unique and valuable characteristics that its FORE-SIGHT oximeter offers for the evaluation of patients with congestive heart failure and related conditions. The paper was published in the March/April 2012 issue of Congestive Heart Failure Journal and is titled “Initial Description of Cerebral Oximetry Measurement in Heart Failure Patients”. It was authored by Dr. Marc Silver and his colleagues at Advocate Christ Medical Center in Oak Lawn, Illinois.
The study, headed by Dr. Silver, compared cerebral oximetry levels and pulse oximetry readings in 30 patients with congestive heart failure. The doctors found that monitoring peripheral pulse oximetry was quite often not predictive of low cerebral oximetry values.
As Dr. Silver reported in the paper, “The interplay between lung function, heart function and cerebral oxygenation is a complicated one.” So the direct measurement of absolute cerebral oximetry values is absolutely necessary to provide unique information not available from other monitoring means. This study is a valuable tool for the sales force of CAS Medical when trying to sell the company’s FORE-SIGHT monitoring system.
For additional information about CAS Medical Systems and its products, please visit the company’s website at www.casmed.com
Let us hear your thoughts below: